食品药品监督管理局对藏药和中药进行认证的途径

Tashi Rabten
{"title":"食品药品监督管理局对藏药和中药进行认证的途径","authors":"Tashi Rabten","doi":"10.15406/IJCAM.2018.11.00418","DOIUrl":null,"url":null,"abstract":"In recent years, the United State’s increasing reliance on Tibetan health practitioners is evidenced by the public’s interest in an alternative to conventional Western medicine. Tibetan medicine has been integrated into and has made large contributions to the U.S. Healthcare system and yet despite all of this recognition and support, Tibetan medicine remains unregulated by US Health and Drug agencies. Measures and guidelines, with exemplars from Germany’s management of botanical medicines, will be used to evaluate how Tibetan medicine meets and exceeds federal standards of medical safety and protection. The results of which will contribute to the public’s knowledge and increase incentives for ongoing research. The ultimate goal is to change the U.S States’ attitude about Eastern medicines so much so that they gain regulation from the Federal Drug Administration.","PeriodicalId":113120,"journal":{"name":"International Journal of Complementary and Alternative Medicine","volume":"119 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"The path towards validating Tibetan and Chinese medicine by the food and drug administration\",\"authors\":\"Tashi Rabten\",\"doi\":\"10.15406/IJCAM.2018.11.00418\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In recent years, the United State’s increasing reliance on Tibetan health practitioners is evidenced by the public’s interest in an alternative to conventional Western medicine. Tibetan medicine has been integrated into and has made large contributions to the U.S. Healthcare system and yet despite all of this recognition and support, Tibetan medicine remains unregulated by US Health and Drug agencies. Measures and guidelines, with exemplars from Germany’s management of botanical medicines, will be used to evaluate how Tibetan medicine meets and exceeds federal standards of medical safety and protection. The results of which will contribute to the public’s knowledge and increase incentives for ongoing research. The ultimate goal is to change the U.S States’ attitude about Eastern medicines so much so that they gain regulation from the Federal Drug Administration.\",\"PeriodicalId\":113120,\"journal\":{\"name\":\"International Journal of Complementary and Alternative Medicine\",\"volume\":\"119 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-11-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Complementary and Alternative Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15406/IJCAM.2018.11.00418\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Complementary and Alternative Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/IJCAM.2018.11.00418","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

近年来,美国越来越依赖西藏医疗从业者,公众对传统西医的替代品感兴趣,这证明了这一点。藏医药已被纳入美国的医疗保健体系,并为其做出了巨大贡献。然而,尽管得到了所有这些认可和支持,藏医药仍然不受美国卫生和药物机构的监管。将以德国植物药管理为例,利用措施和准则来评估藏药如何达到和超过联邦医疗安全和保护标准。其结果将有助于公众的知识,并增加对正在进行的研究的激励。最终目标是改变美国对东方药物的态度,从而获得联邦药物管理局的监管。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The path towards validating Tibetan and Chinese medicine by the food and drug administration
In recent years, the United State’s increasing reliance on Tibetan health practitioners is evidenced by the public’s interest in an alternative to conventional Western medicine. Tibetan medicine has been integrated into and has made large contributions to the U.S. Healthcare system and yet despite all of this recognition and support, Tibetan medicine remains unregulated by US Health and Drug agencies. Measures and guidelines, with exemplars from Germany’s management of botanical medicines, will be used to evaluate how Tibetan medicine meets and exceeds federal standards of medical safety and protection. The results of which will contribute to the public’s knowledge and increase incentives for ongoing research. The ultimate goal is to change the U.S States’ attitude about Eastern medicines so much so that they gain regulation from the Federal Drug Administration.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信